Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
Fabrizio Stocchi, Margherita Torti Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy Abstract: Safinamide (SAF) is a new drug developed for the treatment of Parkinson’s disease (PD). It is a benzylamino derivative with multiple mechanisms of action and antipar...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2016-02-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|